Other Natural Science R&D
Penelitian dan Pengembangan Eksperimental Ilmu Alam
🔬 Section M — Professional, Scientific & Technical
Experimental natural science research and development — conducting controlled laboratory experiments, field trials, and applied research involving biohazards, controlled substances, genetically modified organisms (GMOs), chemical synthesis, pharmaceutical compounds, or other materials requiring specialized safety protocols. This is distinct from observational research (72101) — you're actively manipulating variables, conducting experiments with regulatory oversight, and working with materials that require permits beyond standard lab safety.
What You Need
PP28/2025 Licensing Data3 scales
Post-License Obligations5
Low risk (Rendah)
Basic experimental work without controlled substances or biohazards. NIB auto-issued (Otomatis). Authority: Bupati/Walikota.
Medium-High risk (Menengah Tinggi)
Experiments with moderate hazards (e.g., non-GMO microbiology, chemical synthesis without controlled precursors). NIB + Sertifikat Standar within 7 working days. Authority: Bupati/Walikota (Small/Medium) or Gubernur (Large).
High risk (Tinggi)
Experiments with controlled substances, GMOs, pharmaceutical compounds, or materials requiring BPOM oversight. NIB + Izin within 30 working days. Authority: Gubernur (all scales).
Step-by-step for a PT PMA experimental R&D lab (High risk example)
- Pharmaceutical research — BPOM permit for drug development, clinical trials, or pharmaceutical compound synthesis
- GMO research — Ministry of Agriculture or BPOM clearance for genetically modified organisms
- Controlled substances — BNN (Narcotics Agency) permit for research involving controlled substances
- BSL-2 or BSL-3 lab — if working with biohazards, lab must meet biosafety level standards
- Chemical safety compliance — proper storage, handling, and disposal systems for hazardous materials
Typical total timeline
3–6 months from PT PMA to operational experimental facility (30-day Izin + lab setup + permit acquisition).
Minimum PT PMA capital
IDR 10 billion stated capital (Rp 2.5B paid-up).
Authority
Bupati/Walikota (Low/Medium-High, Small/Medium) · Gubernur (Medium-High Large, all High risk).
Fully open (Terbuka) — 100% foreign ownership.
New code in KBLI 2025 — experimental R&D was previously bundled with general natural science research in KBLI 2020. The 2025 classification separates experimental work (72109) from observational research (72101), recognizing that experimental R&D requires stricter regulatory oversight due to biohazards, controlled substances, and GMOs.
Bali Intelligence
🧪 Experimental R&D in Bali (Niche but Growing Sector)
- Bali has limited experimental R&D infrastructure compared to Jakarta or Surabaya, but niche opportunities exist in pharmaceutical research (traditional medicine compounds), agricultural biotech (tropical crop improvement), and marine biotechnology (coral-derived compounds)
- No BSL-3 facilities in Bali: High-level biohazard research requiring BSL-3 labs is not feasible in Bali; most experimental work is BSL-1 or BSL-2 level
- BPOM coordination required: Any pharmaceutical or GMO research requires BPOM clearance, which is centralized in Jakarta — expect coordination delays
💡 PMA Opportunities in This Sector
- Pharmaceutical R&D: Experimental research on traditional Indonesian medicinal compounds (jamu modernization), natural product drug discovery from tropical plants
- Agricultural biotech: Field trials for crop improvement, organic pesticide development, sustainable farming technologies
- Marine biotechnology: Experimental research on coral-derived compounds, marine organism cultivation, bioprospecting
- Contract research for international pharma: Bali as a tropical research base for pharmaceutical companies conducting natural product screening
⚠ Critical Points for Experimental R&D
- 30 working days for High risk is real: Unlike observational research (72101, 7 days), experimental work with controlled substances or GMOs requires full Izin with 30-day processing — plan accordingly
- BPOM clearance is mandatory for pharma/GMO: Do not start experimental work with pharmaceutical compounds or GMOs without BPOM clearance; enforcement is strict and penalties are severe
- Biosafety compliance is non-negotiable: Labs must meet biosafety standards (BSL-1, BSL-2, or BSL-3 depending on materials); inspections are real
- Import permits for research materials: Importing controlled substances, GMOs, or specialized biological materials requires ministry clearance — this can add 1–3 months to setup timeline
- Distinguish from 72101: If your research is purely observational (no experiments, no controlled substances), use 72101 instead — faster approval, less regulatory burden
- 72101 — Natural science research — if you also conduct observational research alongside experimental work
- 21011 — Pharmaceutical manufacturing — if you move from R&D to commercial drug production
- 21022 — Traditional medicine manufacturing — if you commercialize jamu or traditional medicine products
- 71200 — Technical testing and analysis — if you provide commercial testing services alongside R&D
- 74901 — Environmental consulting — if you conduct environmental impact assessments for experimental field trials
Related Codes
Natural Science R&D
Penelitian dan Pengembangan Ilmu Alam
Engineering & Technology R&D
Penelitian dan Pengembangan Enjinering dan Teknologi
Medical Science R&D
Penelitian dan Pengembangan Ilmu Kedokteran dan
Biotechnology R&D
Penelitian dan Pengembangan Bioteknologi
Agricultural & Fisheries R&D
Penelitian dan Pengembangan Ilmu Pertanian dan
Penelitian dan Pengembangan Ketenaganukliran
Penelitian dan Pengembangan Ketenaganukliran